Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Assets (2016 - 2025)

Tandem Diabetes Care (TNDM) has disclosed Assets for 13 consecutive years, with $874.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Assets fell 8.67% year-over-year to $874.7 million, compared with a TTM value of $874.7 million through Sep 2025, down 8.67%, and an annual FY2024 reading of $967.7 million, up 1.57% over the prior year.
  • Assets was $874.7 million for Q3 2025 at Tandem Diabetes Care, roughly flat from $875.7 million in the prior quarter.
  • Across five years, Assets topped out at $1.1 billion in Q4 2022 and bottomed at $754.3 million in Q1 2021.
  • Average Assets over 5 years is $933.0 million, with a median of $941.0 million recorded in 2024.
  • The sharpest move saw Assets soared 119.7% in 2021, then decreased 10.27% in 2023.
  • Year by year, Assets stood at $905.1 million in 2021, then increased by 16.31% to $1.1 billion in 2022, then fell by 9.51% to $952.7 million in 2023, then rose by 1.57% to $967.7 million in 2024, then fell by 9.61% to $874.7 million in 2025.
  • Business Quant data shows Assets for TNDM at $874.7 million in Q3 2025, $875.7 million in Q2 2025, and $922.1 million in Q1 2025.